Entegris, Inc. — Q1 2012 Form 10-Q
Business context and reporting period
Entegris supplies products and services that purify, protect, and transport critical materials, primarily for semiconductor and related high-technology industries. This unaudited report covers the three months ended March 31, 2012; comparisons are with the three months ended April 2, 2011 unless noted.
Financial results and liquidity
- Net sales were $175.4 million, down 14% year over year. Gross profit was $76.2 million; gross margin held at 43.5%.
- Operating income was $26.8 million (15.3% of sales), down from $37.3 million (18.4%). Net income attributable to Entegris was $17.9 million, or $0.13 per diluted share, versus $29.2 million, or $0.22.
- SG&A was $35.0 million and R&D expense was $12.0 million. Adjusted EBITDA, a non-GAAP measure, was $35.7 million (20.3% of sales), compared with $46.8 million (23.1%). Non-GAAP diluted EPS was $0.14 versus $0.23.
- Operating cash flow was $0.4 million, compared with $11.1 million a year earlier. Capital expenditures were $10.6 million. Cash declined $6.7 million during the quarter to $266.9 million.
- Working capital was $429.4 million. Current assets were $514.6 million and current liabilities $85.2 million. The company reported no short- or long-term debt. Its revolving credit facility had a $30 million commitment; the filing reports no borrowings and $0.3 million related to letters of credit.
Material changes and management commentary
- Management attributed the year-over-year sales decline primarily to weaker semiconductor-industry capital spending that began in the second half of 2011. Unit-driven product sales fell 8%; capital-driven sales fell 24%.
- Sales increased 7% sequentially from Q4 2011, to $175.4 million. Gross margin improved from 41.2% sequentially, principally due to better factory utilization.
- All segments had lower sales year over year: Contamination Control Solutions (CCS) $115.6 million, down 13%; Microenvironments (ME) $40.7 million, down 16%; Specialty Materials (SMD) $19.1 million, down 16%. Segment profits were $32.1 million, $5.5 million, and $4.7 million, respectively.
- Effective tax rate rose to 33.7% from 22.0%. The prior-year rate benefited from a $3.6 million release of a U.S. deferred-tax valuation allowance.
- Receivables and inventories absorbed cash: receivables increased $12.8 million and inventories $7.5 million. Days sales outstanding rose to 62 days from 60 at year-end.
Outlook, risks, and contingencies
No specific revenue or earnings guidance is provided. Management believed cash, available credit facilities, and operating cash flow would be sufficient for working capital and investment needs over the next 12 months. It cautioned that alternative financing might be needed if liquidity proves insufficient, and that acceptable financing may not be available. Key stated business sensitivities include semiconductor cyclicality and capital spending, pricing and competition, sales mix, raw-material costs, factory utilization, and foreign exchange. A 100-basis-point interest-rate change was estimated to affect annual net income by approximately $1.7 million. The company reported ordinary-course legal claims and believed their outcomes would not materially affect its financial statements. Disclosure controls were judged effective; no material change in internal control was reported.
Important facts for investors to verify
- Whether sequential sales improvement continued, given the company’s exposure to semiconductor capital-spending cycles.
- Whether cash conversion improved after the quarter’s low operating cash flow and increases in receivables and inventory.
- How segment sales and profitability evolved, particularly CCS and ME, and whether gross-margin gains were sustained.
- The drivers and sustainability of the 33.7% effective tax rate, including the distinction from the prior-year valuation-allowance benefit.
- Credit-facility availability and the status of letters of credit; the filing’s wording on the $0.3 million amount is not fully clear.